| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alkermes Plc (ALKS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 21 sells. ALKS is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 231.6K | $10.42M | - | |
| CFO | 158.7K | $7.14M | - | |
| VP | 111.5K | $5.02M | - | |
| COO | 27.9K | $1.26M | - | |
| Dir | 25.7K | $1.16M | -2,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2016 | Pugh Gordon G | SVP, COO &CRO, Alkermes, Inc. | Sale+OE | 21,458 | $57.65 | $1,236,984.75 | -34.3% | |
| Dec 15, 2016 | Ehrich Elliot | EVP, R&D &CMO, Alkermes, Inc. | Sale+OE | 5,000 | $55.99 | $279,963.00 | -8.7% | |
| Dec 14, 2016 | Frates James M83 | SVP, Alks Inc; CFO Alks | Sale+OE | 25,000 | $54.73 | $1,368,132.66 | -10.0% | |
| Dec 12, 2016 | Ehrich Elliot | EVP, R&D &CMO, Alkermes, Inc. | Sale+OE | 16,983 | $55.15 | $936,631.13 | -24.4% | |
| Dec 8, 2016 | Biberstein Kathryn L | Evp/ Cao/ CCO Alks Inc; Sec Alks | Sale+OE | 14,145 | $56.13 | $793,966.61 | -8.3% | |
| Dec 7, 2016 | Frates James M83 | SVP, Alks Inc; CFO Alks | Sale+OE | 23,731 | $56.28 | $1,335,631.93 | -6.2% | |
| Dec 1, 2016 | Biberstein Kathryn L | Evp/ Cao/ CCO Alks Inc; Sec Alks | Sale+OE | 15,000 | $56.13 | $841,988.91 | -15.1% | |
| Nov 30, 2016 | Landine Michael J | SVP, Corp Dev., Alkermes, Inc. | Sale+OE | 10,000 | $57.51 | $575,083.00 | -3.1% | |
| Nov 29, 2016 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 30,000 | $56.98 | $1,709,469.25 | -2.4% | |
| Nov 22, 2016 | Pops Richard F57 | Director And CEO, Alkermes Plc | Sale+OE | 30,000 | $58.66 | $1,759,935.64 | -2.4% |